Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bodisen Biotech, Inc. was a China-based agricultural biotechnology company that specialized in the production and distribution of environmentally friendly fertilizers and pesticides. The company's product portfolio included liquid fertilizers, organic-compound fertilizers, and specialized soil conditioners designed to enhance crop yields and promote sustainable farming practices. Based in Shaanxi Province, Bodisen was a pioneer among Chinese firms seeking international capital, listing on the American Stock Exchange (AMEX) under the symbol BODI. However, the company became embroiled in controversy regarding its financial reporting and was delisted from the AMEX in 2007. Its operations have since largely ceased to be visible in international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bodisen Biotech.